| Dr Ashley Schoof, PSYD | |
|
16535 W Bluemound Rd Ste 305, Brookfield, WI 53005 | |
| (800) 438-1772 | |
| (262) 293-9737 |
| Full Name | Dr Ashley Schoof |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 11 Years |
| Location | 16535 W Bluemound Rd Ste 305, Brookfield, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285887174 | NPI | - | NPPES |
| K400482759 | Other | WI | MEDICARE |
| 100028859 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 3572-57 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wisconsin Lutheran Child And Family Service Inc | 0749233898 | 29 |
| Wisconsin Lutheran Child And Family Service Inc | 0749233898 | 29 |
News Archive
Crizotinib is effective in shrinking tumors in patients with anaplastic lymphoma receptor tyrosine kinase (ALK) positive non-small cell lung cancer, a cancer commonly found in people who never smoked, and should be the standard of care for advanced stages of this disease, according to research presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology.
The Los Angeles Times examines the International Medical Corps' work in Afghanistan. "Although less well known than the Nobel-winning Doctors Without Borders, the [International Medical Corps] shares a reputation with its gutsy counterpart for working in places where no one else will go. ... In parts of Afghanistan where government forces have little control, staffers say, they are protected by traditional village councils, known as shuras.
This week, researchers report new findings that clarify the role of NOD2, a key molecular player in Crohn's Disease, in the cellular signaling pathways that control inflammatory responses. NOD2's clinical relevance is clear from the fact that it is encoded by a Crohn's Disease susceptibility gene.
Watson Pharmaceuticals, Inc. today reported a 28 percent increase in net revenue for the first quarter ended March 31, 2010 to $856.5 million, compared to $667.4 million in the first quarter 2009. On an adjusted cash basis, net income increased 25 percent to $100.3 million or $0.81 per share, compared to $80.2 million or $0.69 per share in the first quarter 2009. GAAP earnings for the first quarter 2010 were $0.57 per share, compared to $0.43 per share in the prior year period.
› Verified 7 days ago
| Entity Name | Wisconsin Lutheran Child And Family Service Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083786628 PECOS PAC ID: 0749233898 Enrollment ID: O20050301000318 |
News Archive
Crizotinib is effective in shrinking tumors in patients with anaplastic lymphoma receptor tyrosine kinase (ALK) positive non-small cell lung cancer, a cancer commonly found in people who never smoked, and should be the standard of care for advanced stages of this disease, according to research presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology.
The Los Angeles Times examines the International Medical Corps' work in Afghanistan. "Although less well known than the Nobel-winning Doctors Without Borders, the [International Medical Corps] shares a reputation with its gutsy counterpart for working in places where no one else will go. ... In parts of Afghanistan where government forces have little control, staffers say, they are protected by traditional village councils, known as shuras.
This week, researchers report new findings that clarify the role of NOD2, a key molecular player in Crohn's Disease, in the cellular signaling pathways that control inflammatory responses. NOD2's clinical relevance is clear from the fact that it is encoded by a Crohn's Disease susceptibility gene.
Watson Pharmaceuticals, Inc. today reported a 28 percent increase in net revenue for the first quarter ended March 31, 2010 to $856.5 million, compared to $667.4 million in the first quarter 2009. On an adjusted cash basis, net income increased 25 percent to $100.3 million or $0.81 per share, compared to $80.2 million or $0.69 per share in the first quarter 2009. GAAP earnings for the first quarter 2010 were $0.57 per share, compared to $0.43 per share in the prior year period.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ashley Schoof, PSYD W175n11120 Stonewood Dr, Germantown, WI 53022-6511 Ph: (888) 685-9522 | Dr Ashley Schoof, PSYD 16535 W Bluemound Rd Ste 305, Brookfield, WI 53005 Ph: (800) 438-1772 |
News Archive
Crizotinib is effective in shrinking tumors in patients with anaplastic lymphoma receptor tyrosine kinase (ALK) positive non-small cell lung cancer, a cancer commonly found in people who never smoked, and should be the standard of care for advanced stages of this disease, according to research presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology.
The Los Angeles Times examines the International Medical Corps' work in Afghanistan. "Although less well known than the Nobel-winning Doctors Without Borders, the [International Medical Corps] shares a reputation with its gutsy counterpart for working in places where no one else will go. ... In parts of Afghanistan where government forces have little control, staffers say, they are protected by traditional village councils, known as shuras.
This week, researchers report new findings that clarify the role of NOD2, a key molecular player in Crohn's Disease, in the cellular signaling pathways that control inflammatory responses. NOD2's clinical relevance is clear from the fact that it is encoded by a Crohn's Disease susceptibility gene.
Watson Pharmaceuticals, Inc. today reported a 28 percent increase in net revenue for the first quarter ended March 31, 2010 to $856.5 million, compared to $667.4 million in the first quarter 2009. On an adjusted cash basis, net income increased 25 percent to $100.3 million or $0.81 per share, compared to $80.2 million or $0.69 per share in the first quarter 2009. GAAP earnings for the first quarter 2010 were $0.57 per share, compared to $0.43 per share in the prior year period.
› Verified 7 days ago
Dr. Kathleen M Schoendorf, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 12690 W North Avenue, Elmbrook Family Counseling Center, Brookfield, WI 53005 Phone: 262-785-9188 Fax: 262-785-0644 | |
Dr. Stephen Gary Levine, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 17100 W Bluemound Rd, Suite 204, Brookfield, WI 53005 Phone: 262-391-5780 Fax: 262-754-3712 | |
Dr. Rachel A. Roeglin, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 16535 W Bluemound Rd Ste 200, Brookfield, WI 53005 Phone: 262-789-1191 | |
Kathleen Gehl, PSYD, NP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 13965 W Burleigh Rd, Brookfield, WI 53005 Phone: 262-785-6002 Fax: 262-785-2773 | |
Dr. Stephen Martin Saunders, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 16535 W Bluemound Rd, Suite Number 200, Brookfield, WI 53005 Phone: 262-542-3255 | |
Susan Eileen Donahoo, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 660 Woelfel Rd, Brookfield, WI 53045 Phone: 262-789-8089 | |
Madeline Bliske, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 16535 W Bluemound Rd Ste 200, Brookfield, WI 53005 Phone: 262-789-1191 |